On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.
How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan...
“I think one of the key insights and observations you make when you have a child who's sick and you spend time with other...
"And what I was really surprised about was that everybody was doing data collection in a different way. And I kept thinking that, gosh,...